These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31501046)

  • 1. Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia.
    Elzein HO; Saad AA; Yousif AA; Elamin E; Abdalhabib EK; Elzaki SG
    Curr Res Transl Med; 2020 Apr; 68(2):77-80. PubMed ID: 31501046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study.
    Ahmed NA; Adam I; Elzaki SEG; Awooda HA; Hamdan HZ
    BMC Med Genet; 2019 Jan; 20(1):2. PubMed ID: 30611230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death].
    Santoro R; Iannaccaro P; Sottilotta G
    Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.
    Morrison ER; Miedzybrodzka ZH; Campbell DM; Haites NE; Wilson BJ; Watson MS; Greaves M; Vickers MA
    Thromb Haemost; 2002 May; 87(5):779-85. PubMed ID: 12038776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland.
    Jarvenpaa J; Pakkila M; Savolainen ER; Perheentupa A; Jarvela I; Ryynanen M
    Gynecol Obstet Invest; 2006; 62(1):28-32. PubMed ID: 16514238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia].
    Procházka M; Krcová V; Kudela M; Slavík L
    Ceska Gynekol; 2003 May; 68(3):162-6. PubMed ID: 12879654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilic mutations and susceptibility to preeclampsia in Western Iran.
    Malek-Khosravi S; Rahimi Z; Rahimi Z; Jalilvand F; Parsian A
    J Thromb Thrombolysis; 2012 Jan; 33(1):109-15. PubMed ID: 22068545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
    Couto E; Nomura ML; Barini R; Pinto e Silva JL
    Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy. Relation to pregnancy outcomes for mother and fetus.
    Abu-Skeen IA; Mohamed AA; Moustafa NN; Badawy ME
    Saudi Med J; 2010 Feb; 31(2):123-9. PubMed ID: 20174725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer.
    Paspatis GA; Sfyridaki A; Papanikolaou N; Triantafyllou K; Livadiotaki A; Kapsoritakis A; Lydataki N
    Pathophysiol Haemost Thromb; 2002; 32(1):2-7. PubMed ID: 12214157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of genetic polymorphisms of factor V Leiden and prothrombin in the preeclamptic Polish women.
    Seremak-Mrozikiewicz A; Drews K; Wender-Ozegowska E; Mrozikiewicz PM
    J Thromb Thrombolysis; 2010 Jul; 30(1):97-104. PubMed ID: 20039103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V leiden and factor II G20210A mutations in patients with recurrent abortion.
    Souza SS; Ferriani RA; Pontes AG; Zago MA; Franco RF
    Hum Reprod; 1999 Oct; 14(10):2448-50. PubMed ID: 10527966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications].
    Rajewski M; Skrzypczak J
    Pol Arch Med Wewn; 2006 May; 115(5):417-25. PubMed ID: 17195354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.